| Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.180 | Biomarker | disease | BEFREE | DM-steatohepatitis model was established by dual intraperitoneal injection of streptozotocin (STZ) and feeding with the high-fat diet (HFD) in apolipoprotein E-deficient (ApoE<sup>-/-</sup>) mice (n=40). | 31700865 | 2019 | ||||
|
0.180 | Biomarker | disease | BEFREE | The Influence of Trehalose on Atherosclerosis and Hepatic Steatosis in Apolipoprotein E Knockout Mice. | 30925684 | 2019 | ||||
|
0.180 | Biomarker | disease | BEFREE | In this study, we established the role of the Ron receptor in steatohepatitis-induced hepatic fibrosis using Ron ligand domain knockout mice on an apolipoprotein E knockout background (DKO). | 30091925 | 2018 | ||||
|
0.180 | Biomarker | disease | BEFREE | Pycnogenol protects against diet-induced hepatic steatosis in apolipoprotein-E-deficient mice. | 29462565 | 2018 | ||||
|
0.180 | Biomarker | disease | BEFREE | The aim of this study was to identify RBEE hypolipidemic mechanisms and to study the effects of RBEE on the progression of atherosclerosis disease and linked vascular dysfunction and liver steatosis in apolipoprotein E-knockout (ApoE-/-) mice fed low- or high-fat (LFD, HFD, respectively) and cholesterol diets. | 28359358 | 2017 | ||||
|
0.180 | Biomarker | disease | BEFREE | By comparing mice fed with either a Western high-fat diet or a regular chow diet, we observed that both atherosclerosis and liver steatosis were aggravated in apolipoprotein E-deficient (ApoE<sup>-/-</sup>)/Tollip<sup>-/-</sup> mice as compared with ApoE<sup>-/-</sup> mice. | 28396568 | 2017 | ||||
|
0.180 | Biomarker | disease | BEFREE | We investigated the influence of Alda-1, an activator of ALDH2, on atherogenesis and on the liver steatosis in apolipoprotein E knockout (apoE(-/-)) mice. | 25392542 | 2014 | ||||
|
0.180 | Biomarker | disease | BEFREE | Perfluoroalkyl sulfonates cause alkyl chain length-dependent hepatic steatosis and hypolipidemia mainly by impairing lipoprotein production in APOE*3-Leiden CETP mice. | 21705711 | 2011 | ||||
|
0.180 | Biomarker | disease | HPO |